in an eight-week double-blind study comparing the new long-acting aspirin derivative , diflunisal , in doses up to 1 g/day with aspirin in doses up to 4 g/day in 16 patients with classical or definite rheumatoid arthritis , diflunisal was more effective in reducing the total articular index ( ritchie ) and erythrocyte sedimentation rate and in increasing grip strength .
C0004057
aspirin
C0003873
rheumatoid arthritis